Leutner, M.; Kaleta, M.; Bellach, L.; Kautzky, A.; Thurner, S.; Klimek, P.; Kautzky-Willer, A.
Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years. J. Pers. Med. 2021, 11, 984.
https://doi.org/10.3390/jpm11100984
AMA Style
Leutner M, Kaleta M, Bellach L, Kautzky A, Thurner S, Klimek P, Kautzky-Willer A.
Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years. Journal of Personalized Medicine. 2021; 11(10):984.
https://doi.org/10.3390/jpm11100984
Chicago/Turabian Style
Leutner, Michael, Michaela Kaleta, Luise Bellach, Alexander Kautzky, Stefan Thurner, Peter Klimek, and Alexandra Kautzky-Willer.
2021. "Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years" Journal of Personalized Medicine 11, no. 10: 984.
https://doi.org/10.3390/jpm11100984
APA Style
Leutner, M., Kaleta, M., Bellach, L., Kautzky, A., Thurner, S., Klimek, P., & Kautzky-Willer, A.
(2021). Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years. Journal of Personalized Medicine, 11(10), 984.
https://doi.org/10.3390/jpm11100984